Insider Transactions in Q3 2025 at Syndax Pharmaceuticals Inc (SNDX)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 31
2025
|
Keith A. Goldan Chief Financial Officer |
BUY
Other acquisition or disposition
|
Direct |
1,226
+1.29%
|
$9,808
$8.43 P/Share
|
|
Jul 16
2025
|
Michael A Metzger Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
7,534
-2.46%
|
$67,806
$9.29 P/Share
|
|
Jul 16
2025
|
Keith A. Goldan Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,296
-1.38%
|
$11,664
$9.29 P/Share
|